Evogen, Inc. — Form D
Evogen, Inc. of Lenexa, KS, a company, filed a Form D exempt-offering notice with the SEC on 2014-02-19. The offering totals $1.6M, of which $852K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-02-19
- Form: D
- Accession: 0001170875-14-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $852K
- Remaining: $728K
- Investors: 8
- Date of first sale: 2014-01-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-212167
Issuer
- Name: Evogen, Inc.
- CIK: 0001170875
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 10513 W. 84th Terrace, Lenexa, KS, 64214
- Phone: 913-312-5676
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Hans Kastensmith | Director | Lenexa, KS |
| Nathan Ledeboer | Director | Lenexa, KS |
| Jonathan Leitersdorf | Director | Lenexa, KS |
| Sean Reineke | Director | Rockville, MD |
| Robert Dondes | Executive Officer | Lenexa, KS |
| Hans Kastensmith | Executive Officer | Lenexa, KS |
| Richard St. Clair | Executive Officer | Lenexa, KS |
| Hans Kastensmith | Promoter | Lenexa, KS |
| John Levy | Director | Poughkeepsie, NY |
| Thomas Jantsch | Director | Kansas City, MO |
| Thomas Jantsch | Executive Officer | Kansas City, MO |
| James Spigarelli | Director | Kansas City, MO |
Other filings by this issuer (1)
More